Avalyn Pharma Inc. AVLN
28.70 USD +1.01 (+3.65%)
Regular-session close
28.14 -0.56 -1.95%
After hours · Nov 19, 6:07 PM ET
27.01 Day range 28.90
23.33 52-week range 39.25
- YTD
- -2.68%
- 1 year
- -2.68%
Benzinga news
benzinga.com Morgan Stanley Maintains Overweight on Avalyn Pharma, Lowers Price Target to $53 Morgan Stanley analyst Judah Frommer maintains Avalyn Pharma (NASDAQ:AVLN) with a Overweight and lowers the price target from $57 to $53.
benzinga.com Avalyn Pharma Q3 EPS $(0.67) Beats $(0.75) Estimate Avalyn Pharma (NASDAQ:AVLN) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(0.75) by 10.67 percent. This is a 96.71 percent increase over losses of…
